Dynamic Purchasing System for Commonly Used Pharmaceutical Products
Originaltitel der Bekanntmachung
Bulgaria – Pharmaceutical products – Динамична система за покупки на обичайно използвани лекарствени продукти за нуждите на МБАЛ „Свети Пантелеймон – Пловдив“ ЕООД
Opportunity Score
Warum diese Bewertung?
Chance
70 / 100
Komplexität
60 / 100
Risikofaktoren
EU funding flag is true in structured data but XML notice indicates 'no-eu-funds'. This may affect contract terms or bu...
Stringent licensing requirements (wholesale, narcotics, import permits) may exclude some suppliers.
Restricted procedure — pre-qualification required
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Überblick
Strong opportunityWichtige Fakten
- EUR 3.3M estimated value
- Dynamic Purchasing System (DPS)
- Supplies contract
- 1 lot
- Duration 48 MONTH
- Supply of pharmaceutical products to the hospital
- Products may include those from the Positive Drug List and others
Vollständige Zusammenfassung anzeigen
This tender establishes a Dynamic Purchasing System (DPS) for the supply of commonly used pharmaceutical products to the hospital MBAL 'Sveti Panteleymon – Plovdiv' EOOD, including products from the Positive Drug List and others. The DPS has a single lot (LOT-0001) and a duration of 48 months. The procedure is restricted, and the award criterion is the lowest price.
Risiken
EU funding flag is true in structured data but XML notice indicates 'no-eu-funds'. This may affect contract terms or bu...
Stringent licensing requirements (wholesale, narcotics, import permits) may exclude some suppliers.
Restricted procedure — pre-qualification required
Analyse kann unvollständig sein
Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.
Wichtige Anforderungen
Technical
- Participation is restricted to the second stage of the DPS after initial selection
Administrative
- Electronic submission is required
- Tenders must be submitted via the CAIS EOP platform
Anforderungen können unvollständig sein.
Zuschlagskriterien
Lot 1
Auftraggeber
Ort
гр. Пловдив, BGR
Website
Auftraggeberprofil
Kennung
115517517
Tätigkeit
Health
Lose (1)
LOT-0001
Dynamic Purchasing System for Commonly Used Pharmaceutical Products
Supply of pharmaceutical products, including those listed in Appendix 2 of the Positive Drug List and others not listed, to meet the needs of the hospital's medical units.
EUR 3.3M
Geschätzter Wert
Ort
Dauer
Kategorie
Zuschlagskriterien
Frist
Zuschlagsdetails
Оценяването и класирането на офертите на участниците се извършва по критерия „НАЙ-НИСКА ЦЕНА”, съгласно чл. 70, ал. 2, т. 1 от ЗОП.
Hinweis zum Wert
Originale TED-Daten anzeigen
Originaler Los-Titel
Динамична система за покупки на обичайно използвани лекарствени продукти за нуждите на МБАЛ „Свети Пантелеймон – Пловдив“ ЕООД
Originale TED-Beschreibung
В рамките на динамичната система за покупки (ДСП) ще бъдат възлагани обществени поръчки за доставки на обичайно използвани лекарствени продукти за нуждите на МБАЛ „Свети Пантелеймон – Пловдив“ ЕООД, в това число лекарствени продукти, включени в Приложение №2 на Позитивния лекарствен списък, както и лекарствени продукти, които не са включени в ПЛС, като с поръчките се цели се цели да се обезпечат работните нужди на медицински звена, обособени и функциониращи в лечебното заведение.
Vergabedetails
- Veröffentlichungsdatum
- 15 Jun 2026
- Sprachen
- Bulgarian
Referenzmetadaten
- Rechtsgrundlage
- 32014L0024
Referenz-IDs
- Ausschreibungs-ID
- 410285-2026
Dokumente (1)
Ähnliche Ausschreibungen
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Belgium – Pharmaceutical products – Antimycotica
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Opportunity Score
Warum diese Bewertung?
Chance
70 / 100
Komplexität
60 / 100
Risikofaktoren
EU funding flag is true in structured data but XML notice indicates 'no-eu-funds'. This may affect contract terms or bu...
Stringent licensing requirements (wholesale, narcotics, import permits) may exclude some suppliers.
Restricted procedure — pre-qualification required
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications